HOTAIR primes the Ewing sarcoma family of tumors for tumorigenesis via epigenetic dysregulation involving LSD1

The EWS-FLI1 fusion protein drives oncogenesis in the Ewing sarcoma family of tumors (ESFT) in humans, but its toxicity in normal cells requires additional cellular events for oncogenesis. We show that the lncRNA HOTAIR maintains cell viability in the presence of EWS-FLI1 and redirects epigenetic regulation in ESFT. HOTAIR is consistently overexpressed in ESFTs and is not driven by EWS-FLI1. Repression of HOTAIR in ESFT cell lines significantly reduces anchorage-independent colony formation in vitro and impairs tumor xenograft growth in vivo. Overexpression of HOTAIR in human mesenchymal stem cells (hMSCs), a putative cell of origin of ESFT, and IMR90 cells induces colony formation. Critically, HOTAIR-expressing hMSCs and IMR90 cells remain viable with subsequent EWS-FLI1 expression. HOTAIR induces histone modifications and gene repression through interaction with the epigenetic modifier LSD1 in ESFT cell lines and hTERT-hMSCs. Our findings suggest that HOTAIR maintains ESFT viability through epigenetic dysregulation. Significance While the EWS-FLI1 fusion gene was determined to be the oncogenic driver in the overwhelming majority of ESFT, it is toxic to cell physiology and requires one or more additional molecular events to maintain cell viability. As these tumors have surprisingly few genetic mutations at diagnosis, epigenetic changes have been considered to be such an event, but the mechanism by which these changes are driven remains unclear. Our work shows that HOTAIR is consistently expressed among ESFT and induces epigenetic and gene expression changes that cooperate in tumorigenesis. Furthermore, expression of HOTAIR allows for cell viability in the setting of subsequent EWS-FLI1 expression. Our findings elucidate new steps of malignant transformation in this cancer and identify novel therapeutic targets.

[1]  S. Lessnick,et al.  Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth , 2017, Proceedings of the National Academy of Sciences.

[2]  Ming Sun,et al.  LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation , 2017, Molecular Cancer.

[3]  D. Duboule,et al.  Hotair Is Dispensible for Mouse Development , 2016, PLoS genetics.

[4]  C. Hartmann,et al.  Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation , 2016, Cell Death and Disease.

[5]  Wolfgang Wagner,et al.  The lncRNA HOTAIR impacts on mesenchymal stem cells via triple helix formation , 2016, Nucleic acids research.

[6]  Sunyeong Lee,et al.  Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells , 2016, Toxicological research.

[7]  D. Surdez,et al.  Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model , 2016, Oncotarget.

[8]  Hu Pu,et al.  LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2 , 2015, Oncotarget.

[9]  W. Schulz,et al.  The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells , 2015, Molecular Cancer.

[10]  R. Margueron,et al.  Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation , 2015, Molecular cell.

[11]  Cathy H. Wu,et al.  Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing , 2015, Proceedings of the National Academy of Sciences.

[12]  T. Triche,et al.  Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the Children's Oncology Group , 2015, The journal of pathology. Clinical research.

[13]  Abbas Shirinifard,et al.  Targeting the DNA repair pathway in Ewing sarcoma. , 2014, Cell reports.

[14]  A. Beaudet,et al.  Towards a therapy for Angelman syndrome by reduction of a long non-coding RNA , 2014, Nature.

[15]  Tao Yang,et al.  Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis , 2014, Breast Cancer Research.

[16]  Yu-qin Pan,et al.  Prognostic Value of Long Non-Coding RNA HOTAIR in Various Cancers , 2014, PloS one.

[17]  Li Ding,et al.  Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. , 2014, Cancer discovery.

[18]  A. McKenna,et al.  The genomic landscape of pediatric Ewing sarcoma. , 2014, Cancer discovery.

[19]  Jun S. Wei,et al.  The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation , 2014, PLoS genetics.

[20]  M. Beckerle,et al.  Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth , 2014, Clinical Cancer Research.

[21]  Nilay Shah,et al.  PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13-cis Retinoic Acid–Mediated Differentiation in Neuroblastoma , 2014, Clinical Cancer Research.

[22]  D. Osuna,et al.  Characterization of Human Mesenchymal Stem Cells from Ewing Sarcoma Patients. Pathogenetic Implications , 2014, PloS one.

[23]  H. Kovar,et al.  Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs , 2014, Epigenetics.

[24]  Matheus C. Bürger,et al.  Brief Report: The lincRNA Hotair Is Required for Epithelial‐to‐Mesenchymal Transition and Stemness Maintenance of Cancer Cell Lines , 2013, Stem cells.

[25]  R. Bell,et al.  Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma , 2012, Oncogene.

[26]  Toshio Mori,et al.  Comparison of Gene Expression Profiling in Sarcomas and Mesenchymal Stem Cells Identifies Tumorigenic Pathways in Chemically Induced Rat Sarcoma Model , 2012, ISRN oncology.

[27]  F. Clavel-Chapelon,et al.  Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma , 2012, Nature Genetics.

[28]  S. Diederichs,et al.  Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. , 2011, Genome research.

[29]  S. Knuutila,et al.  High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients , 2011, ISRN oncology.

[30]  Patrick Schorderet,et al.  Structural and Functional Differences in the Long Non-Coding RNA Hotair in Mouse and Human , 2011, PLoS genetics.

[31]  S. Xie,et al.  Bone Marrow Mesenchymal Stem Cell Has Poor Proliferation but Non-Tumorigenicity in Cancer Environment , 2010 .

[32]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[33]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[34]  Anushya Muruganujan,et al.  PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium , 2009, Nucleic Acids Res..

[35]  Mirko Francesconi,et al.  Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  S. Nelson,et al.  Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors , 2008, Laboratory Investigation.

[37]  Stephen L. Lessnick,et al.  EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma , 2008, PloS one.

[38]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[39]  O. Delattre,et al.  Mesenchymal stem cell features of Ewing tumors. , 2007, Cancer cell.

[40]  J. Eberwine,et al.  Immunoprecipitation of mRNA-protein complexes , 2006, Nature Protocols.

[41]  T. Golub,et al.  Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. , 2006, Cancer cell.

[42]  C. Denny,et al.  The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.

[43]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[44]  M. Gagliardi,et al.  RIP: RNA Immunoprecipitation. , 2016, Methods in molecular biology.

[45]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[46]  Frank Berthold,et al.  Erratum: Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma (Cancer Research (October 1, 2004) 64 (6883-6891)) , 2005 .